Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders

Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders

US Patent 12115169 · Granted Oct 15, 2024

Estimated economic value: $2,479,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treating tuberous sclerosis complex2024